Alexandre Harlé

20PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsImmunogenetics (incl. genetic immunology)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 03, 2026
Impact of Tumor Genomic Profile on Adjuvant Chemotherapy Efficacy in Resected Pancreatic Adenocarcinoma: Results From the PRODIGE-24/CCTG PA6 Study.

|Feb 06, 2026
Genetic variant interpretation in tumours in the French national ring trials Gen&Tiss - main criteria of improvement.

Medina Kalimulaeva, Leen Van Langenhoven, Karen Leroy

|Jan 28, 2026
Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection of IDH Variants in Solid Tumors and Hematological Malignancies.

Pauline Gilson, Marc Muller, Guillaume Gauchotte

|Dec 23, 2023
Integrated Molecular Characterization of HER2-Low Breast Cancer Using Next Generation Sequencing (NGS).

Jean-Louis Merlin, Marie Husson, Nassim Sahki

|Nov 14, 2023
Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial.

Rémy Nicolle, Jean-Baptiste Bachet, Alexandre Harlé

Pageof 4